Borsche et al. (204) identified elevated IL-6 in PINK1 and Parkin patient blood compared with unaffected controls, whereas heterozygous carriers and sporadic PD patients only had a trend toward increased IL-6. This evidence concerns the gene IL6 and Parkinson disease.